Know the Facts about Spinocerebellar Ataxia and a New Clinical Study [Infographic]


Posted: September 20, 2019 | Word Count: 43

Ataxia, a rare and progressive neurological disease, affects nearly 150,000 people in the U.S. A new clinical study will measure if troriluzole, an investigational drug, will improve ataxia symptoms in people with spinocerebellar ataxia (SCA). Learn more at www.scatrial.org.


This article is available to download for free use in print and online publications. If you must edit the article, please include at least one brand reference. All articles must retain the (BPT) or Brandpoint byline.
Download this Article